last posts

The global allergy diagnostics market is estimated to reach a value of US$5.6 billion in 2033 and exceed revenue of US$11.8 billion at a CAGR of 7.7% during the forecast period 2023-2033


Future Market Insights Global and Consulting Pvt.  ltd.

Future Market Insights Global and Consulting Pvt. ltd.

Increased reliance on R&D to develop innovative diagnostic products Significant impact on market growth. The allergy diagnostics market is expected to grow at 7.7% CAGR through 2033. Rising air pollution and growing prevalence of asthma are fueling the demand for allergy diagnostics

DUBAI, United Arab Emirates, Dec. 31 2022 (GLOBE NEWSWIRE) — The allergy diagnostics market is expected to grow at a CAGR of 7.7% during the forecast period. The global market was valued at US$5.6 billion in 2023 and is expected to reach US$11.8 billion by 2033.

As pollution levels rise, the allergy diagnostics market is expected to grow. Major risk factors for chronic respiratory disease include exposure to allergens, occupational exposure, and exposure to indoor and outdoor air pollution.

Due to their greater exposure to pollutants, city dwellers are more likely than rural dwellers to suffer from allergic disorders. Rise in food allergies is expected to drive the market opportunities for allergy diagnostics.

Request a sample@

The prevalence of sensitive skin and its tendency to irritation have increased due to climate change, air pollution, and the complexity of materials and cosmetics. These reasons are expected to generate market opportunities for allergy diagnostics in the near future.

Regional outlook

North America led the global market in terms of region. Growing number of allergy sufferers, improved healthcare infrastructure, and advanced diagnostic technologies are major drivers for the boom in the North American allergy diagnostics market.

In addition, the growth of the allergy diagnostics market is driven by the prominence of leading allergy diagnostics suppliers and manufacturers who offer revolutionary allergy diagnostic tests. As pharmaceutical allergy-related mortality increases, the demand for rapid and accurate allergy diagnostics will also increase.

The high frequency of allergic rhinitis (hay fever) and the prevalence of skin allergies among black Americans, including eczema and skin inflammation, will fuel the expansion of the allergy diagnostics market in the United States.

The US allergy diagnostics market is expected to grow at a CAGR of 7.1% during the forecast period. The US market is expected to reach $4.4 billion by 2023.

Awareness programs put in place by government and non-governmental groups to prevent mortality from food and drug allergies will have a positive impact on the need for allergy diagnosis in the healthcare sector.

Limited time offer, get 30% off:

Segmentation insights

Information on types of allergens

The inhalant allergen sub-segment led the market by allergen. Rising levels of pollen and environmental pollution, among other factors, may contribute to the expansion of the allergy diagnostics market in the inhalant allergen sub-segment. All of these variables have the potential to increase consumer demand for inhaled allergens and accelerate market growth. During the projected period, these are expected to be the major drivers of the allergy diagnostics market size.

Competitive landscape

The allergy diagnostics market is fragmented and competitive, with many leading players in allergy diagnostic devices. The presence of major companies in the field of allergy diagnostic devices such as BioMérieux SA, Thermo Fischer Scientific Inc, Omega Diagnostics, Siemens Healthineers AG, Minaris Medical America and Danaher Corporation enhances the competitiveness of the market.

Increasing innovation and investment by various public and private entities is expected to exacerbate industrial rivalry around the world.

Using a single finger prick, people can test themselves at home for a variety of common food and respiratory allergies as part of STAT Medical’s initial product line, which launched in August 2022.

A new Allergyfocus test was introduced in June 2022 by Cambridge-based Oncologica, a leading healthcare testing centre, to help patients know which prevalent environmental allergens their body is sensitive to.

Ask an analyst@

key segment

By product type:

By type of allergen:

  • Inhaled allergens

  • Food allergens

  • Drug allergens

  • Other allergens

By type of exam:

  • In vivo allergy testing

  • In vitro allergy tests

Per end user:


1. Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply-side trends

1.4. Analysis of the technology roadmap

1.5. Analysis and recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limits

3. Market Context

3.1. Market dynamics

3.1.1. Drivers

3.1.2. Constraints

3.1.3. Opportunity

3.1.4. Tendencies

3.2. Scenario forecast

3.2.1. Demand in the optimistic scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in the conservative scenario

3.3. Opportunity Map Analysis

Browse full report @

About Healthcare at Future Market Insights

The Future Market Insights healthcare team offers expert analysis, timely research, and strategic recommendations with the aim of providing authentic information and accurate results to help customers around the world. With a repository of over 100 reports and over a million data points, the team has been insightfully analyzing the industry in over 50 countries for over a decade. The team provides a brief analysis of key trends, including the competitive landscape, profit margin, and research development efforts.

Take a look at related reports from the health field

Transcranial Doppler Ultrasound System Market: The Global Market transcranial Doppler ultrasound market is expected to reach revenue of approximately US$658.4 million by 2032, from US$299.2 million in 2022, growing at a CAGR of 7.4% during the forecast period.

Preventive medicine market: According to IMF analysts, the global market preventive medicine market is estimated at 372 billion US dollars in 2022 and should increase to a CAGR of 4.8% in the forecast period from 2022 to 2032. The global preventive medicine market share is expected to reach US$623.6 billion by 2032.

Advanced Infusion Systems Market: The Global Market advanced infusion systems market is likely to be valued at US$8,470.25 million in 2022 and is expected to secure a slow-paced CAGR of 6.4% during the forecast period. The market is expected to grow to a value of US$15,820.03 million by 2032.

Kaempferol Market: The kaempferol marketwhich has a valuation of US$3.91 billion in 2022, is expected to grow at a CAGR of 4% over the forecast period and is expected to be valued at US$5.79 billion by 2032.

Brain Imaging and Neuroimaging Market: The Global Market Brain Imaging and Neuroimaging Market should be worth US$13,166.5 million by 2022, and is expected to grow at a moderate CAGR of 5.1% between 2022 and 2032, totaling approximately US$21,569.7 million by 2032.

About Future Market Insights (IMF)

Future Market Insights, Inc. is an ESOMAR certified business consulting and market research firm, member of the Greater New York Chamber of Commerce and headquartered in Delaware, USA. Recipient of the 2022 Clutch Leaders Award for high customer score (4.9/5), we have partnered with global companies on their business transformation journey and helped them realize their business ambitions. 80% of the Forbes 1000 largest companies are our clients. We serve global clients across all leading and niche market segments in all major industries.

Contact us:

Future Market Insights, Inc.
1602-6 Jumeirah Bay Tower X2,
Parcel number: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs | Youtube
For sales inquiries:
Old Source:



Font Size
lines height